Watch National Geographic Feature
Watch Before and After Recovery
Scottsdale, AZ– November 29th, 2018 - RenovaCare, Inc., (Symbol: RCAR; www.renovacareinc.com) today announced an equity financing for $15.5 million from Kalen Capital Corporation, the family office of Mr. Harmel S. Rayat, majority shareholder and Chairman of RenovaCare. This increases his family office’s total equity investment in RenovaCare since 2013 to over $20 million.
Scottsdale, AZ - October 26, 2018 - RenovaCare, Inc., (OTC: RCAR),developer of patented technologies* for isolating and spraying a patient’s own stem cells onto burns and wounds for rapid self-healing, today announced the appointment of Mr. Steve Yan-Klassen, CPA, CMA, as its Chief Financial Officer.
RenovaCare, Inc., (RCAR), announces the appointment of Mr. Harmel S. Rayat, longtime majority stockholder, as Chairman of its Board of Directors.
Technology Q&A | View All
The CellMist™ System is an innovative investigational medical treatment for processing and spraying a patient's own stem cells onto wounds for rapid healing.
The CellMist™ System is comprised of two primary components:
Once sprayed onto the wound site, the patient's stem cells contained in the CellMist™ Solution go to work, naturally and rapidly regenerating damaged skin.
The CellMist™ System replaces traditional skin grafts, harvested through painful surgery to re
Our patented SkinGun™ is an investigational spray device specially designed to deliver the CellMist™ Solution and its regenerative stem cells to heal burns and wounds.
Stem cells are delicate and can be easily damaged by conventional spray methods. These pumps use mechanical compression, generating turbulent forces which can thrash and damage the cells.
In contrast, the SkinGun™ is an ultra-gentle sprayer, which delicately carries the patient's own stem cells to wound sites. We make use of a novel positive-pressure system engineered to avoid violent forces.
The CellMist™ System sprays a patient's own stem cells onto wounds, naturally regenerating skin to heal traumatic wounds quicker than traditional therapies.
First, a patient's cells are liberated from a small sample of skin, often as little as a postage stamp. These naturally potent cells are collected in a water-based liquid called the CellMist™ Solution.
Next, the CellMist™ Solution is sprayed gently onto the wounded area using our patented investigational SkinGun™.
This procedure takes as little as 90 minutes from start to finish. In some cases, patients can leave the hospital within a few days, rather than the many weeks required by alternative treatments.
The CellMist™ System has been used in experimental procedures to treat severe second-degree burns.
Our future target markets include chronic wounds, vitiligo (areas of unpigmented skin), scars, and other skin disorders, which collectively account for a $45 billion market and 143 million patients.
The CellMist™ System is under development and has only been used in experimental protocols on a very limited basis. Our technologies are not currently available for use or treatment in the United States.
RenovaCare’s Solution Spray Deposition Device was designed to meet a specific clinical need. Liquid spraying, such as saline solution spraying to cleanse a wound, to irrigate a wound, or to maintain a moist wound environment is clinically desirable in surgery. While saline and other wound-wetting solutions' distribution over burns and other wounds is typically performed by pouring the liquid or squirting with a standard syringe, RenovaCare has developed a device that sprays gently and evenly over a large wound area.
Visit the Investor Dashboard for More Detailed Information
